These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8351000)

  • 1. Progression after chronic manganese exposure.
    Huang CC; Lu CS; Chu NS; Hochberg F; Lilienfeld D; Olanow W; Calne DB
    Neurology; 1993 Aug; 43(8):1479-83. PubMed ID: 8351000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term progression in chronic manganism: ten years of follow-up.
    Huang CC; Chu NS; Lu CS; Chen RS; Calne DB
    Neurology; 1998 Mar; 50(3):698-700. PubMed ID: 9521259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
    Chu NS
    Neurology; 2004 Oct; 63(8):1541; author reply 1541. PubMed ID: 15505194
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa failure in chronic manganism.
    Lu CS; Huang CC; Chu NS; Calne DB
    Neurology; 1994 Sep; 44(9):1600-2. PubMed ID: 7936281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of welder presenting with parkinsonism after chronic manganese exposure].
    Sato K; Ueyama H; Arakawa R; Kumamoto T; Tsuda T
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1110-5. PubMed ID: 11332192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate).
    Meco G; Bonifati V; Vanacore N; Fabrizio E
    Scand J Work Environ Health; 1994 Aug; 20(4):301-5. PubMed ID: 7801076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders.
    Searles Nielsen S; Checkoway H; Criswell SR; Farin FM; Stapleton PL; Sheppard L; Racette BA
    Parkinsonism Relat Disord; 2015 Apr; 21(4):355-60. PubMed ID: 25634431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganism and idiopathic parkinsonism: similarities and differences.
    Calne DB; Chu NS; Huang CC; Lu CS; Olanow W
    Neurology; 1994 Sep; 44(9):1583-6. PubMed ID: 7936278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.
    Sikk K; Taba P
    Int Rev Neurobiol; 2015; 120():257-71. PubMed ID: 26070761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter.
    Wang JD; Huang CC; Hwang YH; Chiang JR; Lin JM; Chen JS
    Br J Ind Med; 1989 Dec; 46(12):856-9. PubMed ID: 2611159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure.
    Hageman G; van der Hoek J; van Hout M; van der Laan G; Steur EJ; de Bruin W; Herholz K
    J Neurol; 1999 Mar; 246(3):198-206. PubMed ID: 10323318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
    Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
    J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
    Kim Y; Kim JM; Kim JW; Yoo CI; Lee CR; Lee JH; Kim HK; Yang SO; Chung HK; Lee DS; Jeon B
    Mov Disord; 2002 May; 17(3):568-75. PubMed ID: 12112209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese induced parkinsonism: a case report.
    Kim JW; Kim Y; Cheong HK; Ito K
    J Korean Med Sci; 1998 Aug; 13(4):437-9. PubMed ID: 9741552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia.
    Silver M; Factor SA
    Parkinsonism Relat Disord; 2013 Aug; 19(8):758-60. PubMed ID: 23632325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levodopa treatment for parkinsonism in welders: A double-blind study.
    Koller WC; Lyons KE; Truly W
    Neurology; 2004 Mar; 62(5):730-3. PubMed ID: 15007122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese as possible ecoetiologic factor in Parkinson's disease.
    Feldman RG
    Ann N Y Acad Sci; 1992 May; 648():266-7. PubMed ID: 1637054
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa].
    Fernández Pardal MM; Gatto E; Micheli F; Casas Parera I; Diaz S
    Medicina (B Aires); 1991; 51(6):561-7. PubMed ID: 7476112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease.
    De Michele G; Mengano A; Filla A; Trombetta L; Campanella G
    Acta Neurol (Napoli); 1989 Dec; 11(6):408-14. PubMed ID: 2694799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.